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Abstract 
The lack of knowledge of current public attitudes towards basic research into 
induced pluripotent stem cells (iPSCs) is a serious problem when considering 
appropriate ways of governance regarding research and its clinical applications. We 
therefore conducted an internet-based survey to determine public opinion regarding 
the research and development of iPSCs and regenerative medicine (RM). A total of 
14,908 valid responses were collected, which revealed that the Japanese public were 
familiar with the terms iPSCs and RM, and many of them had received information 
about iPSCs and RM through the television and newspapers. They also generally 
accepted the need for extra funding for research into iPSCs, but also decided to 
adopt a “wait and see” approach and thought that research and development of 
iPSCs and RM should be conducted under proper governance in accordance with an 
international regulatory framework. It will be necessary to discuss an 
internationally consistent regulatory system and effective mechanisms for 
information flow. 
  





Science news from Japan and the United States in 2007 regarding the successful 
generation of induced pluripotent stem cells (iPSCs) through the direct 
reprogramming of somatic cells in vitro [1,2] traveled all over the world and 
impacted upon not only scientific fields, but also the public sphere. In Japan, iPSCs 
have been reported and discussed in all forms of media. Following a global trend to 
encourage the research and development of iPSCs and derived products in light of 
their expected impact, importance and benefits, the Japanese Ministry of Education, 
Sports, Culture, Science and Technology (MEXT) decided to invest 10 billion yen 
into promoting the research and development of iPSCs over a 5-year period 
beginning March 2008 [3]. 
 The importance of adequate governance of advanced science has been 
discussed previously [4,5], and this applies to stem cell research. Many factors need 
to be considered in order to ensure proper governance, including social climate and 
public opinion. Several studies concerning public opinion about stem cell research 
have been conducted [6–8], but few large-scale investigations have focused on public 
attitudes towards iPSCs. One exception was a telephone-based survey conducted by 
a research group at Virginia Commonwealth University (VCU). They asked 1,000 
Americans their opinions regarding stem cells, including iPSCs [8]. To the best of 
our knowledge, no subsequent large-scale investigations into public attitudes 
towards iPSCs have been conducted, despite the rapid movement forward on 
governance, funding decisions and iPSC research and development, and the rapid 
broadcasting of iPSC issues by the mass media. Considering that iPSCs have 
opened a new dialogue with respect to the basic research and clinical applications of 
pluripotent stem cells (PSCs), the lack of knowledge on current public attitudes 
towards iPSCs is a serious problem. We therefore conducted an internet-based 
survey in conjunction with the Asahi newspaper, one of the most prestigious 
newspapers in Japan with a circulation of approximately eight million [9]. This 
survey was open to the public and sought to determine their opinions regarding the 






This was a web-based survey. A questionnaire was sent to members of the Asahi 
newspaper portal site and readers of the Asahi newspaper. Because public attitudes 
towards iPSCs and RM in Japan are unknown, we designed the questions to 
determine the public attitude towards and their recognition of iPSCs and RM. This 
research focused on the public recognition of iPSCs and RM and their opinions 
concerning the future prospects for and necessary regulation of these techniques, 
and their willingness to be actively involved. The questionnaire contained 16 
questions, including three questions concerning the respondents’ backgrounds and a 
question allowing free description of the respondents’ images of iPSCs and advanced 
life science research (Table 1). The results of this aspect of the questionnaire are not 
discussed here. We provided a brief introduction to the current situation of iPSCs 
and RM research, where we aimed to offer information on both the potential 
benefits and risks of iPSCs and RM, based on the opinions of scientists and the 
information broadcast in the media. All the questions required the respondents to 
choose one answer that best described their attitude. A total of 14,908 valid 
responses were collected in the 5-day period from the 5th to 9 September 2008. We 
are unable to present all the data here, but report on some of the significant results 
regarding the current public attitudes to iPSCs and RM in Japan. 
 To reduce confusion and prevent the questionnaire being too diffuse, we did 
not ask about people’s recognition of research into stem cells or embryonic stem (ES) 
cells. Although many Japanese people seem to be aware of the terms ES cells and 
stem cells, it seemed likely that they would not know the difference between 
different types of stem cells. It was therefore decided that this research would focus 
on iPSCs and RM, which are the most significant and popular topics with the public 
in the field of advanced life sciences. A detailed investigation of public attitudes 




The nature of internet-based research is associated with a potential for bias. While 
it has the advantages of low cost, rapid and easy collection of answers, easy 
limitation of target respondents, etc., possible disadvantages include a bias towards 
wealthy and more highly-educated respondents (particularly towards older people 
who can easily access the internet) [10]. In addition, the respondents were all 
readers of the Asahi newspaper and internet users, and were therefore possibly 
more conscious of social problems and had easier internet access than would have 
been the case had respondents been sampled at random. There were also possible 
biases in terms of age and sex ratios (Table 2). Respondents under the age of 20 
were in a minority, and our results may therefore not adequately reflect the 
opinions of younger members of the public towards iPSC and RM. However, 
considering the large number of respondents (14,908), it seems likely that the 





Demographics of respondents 
 
The demographics of the respondents with regard to age and sex are shown in Table 
2. Of the total 14,908 respondents, 63.2% were male and 36.8% were female. 
Concerning their ages, 0.8% were < 19 years, 3.8% were 20–29 years, 12.8% were 
30–39 years, 27.7% were 40–49 years, 27.6% were 50–59 years, 20.0% were 60–69 
years and 7.4% were over 70 years. 
 
Recognition of iPSCs and RM by the Japanese public 
 
There was surprisingly high recognition by the public of the terms iPSCs and RM. 
The term iPSCs was recognized by 73.7% of the respondents, while 87.3% 
recognized the term RM. The results of a cross analysis of recognition between 
iPSCs and RM are shown in Table 3. This result indicates that the majority of 
Japanese readers of the Asahi newspaper were aware of these terms.  
 
Public attitudes to iPSCs and RM in Japan 
 
Concerning the necessity for research and development of iPSCs and RM, 44.6% of 
respondents thought it “very necessary” and 45.7% thought it “necessary” (Fig. 1). 
In addition, 57.6% believed it should be encouraged with more research funding, 
while 17.0% believed it should be continued with the same level of funding (Fig. 2). 
This suggests that many respondents accepted the necessity for continued research 
and into iPSCs and RM, and the possible need for extra funding. With respect to 
sex- and age-related responses, there was a tendency for older and male 
respondents to be more positive supporters of iPSC and RM research (data not 
shown). A similar tendency was identified when respondents were asked about the 
prospect of RM becoming a reality; a total of 65.4% said they believed it would be 
possible “within 10 years” (Fig. 3). Regarding progress and competition in research 
into iPSCs and RM, 34.9% of the respondents thought that Japan should establish a 
pioneering research system, and 51.4% of the respondents believed that research 
and development should progress with international cooperation (Fig. 4). 
 Concerning respondents’ willingness to cooperate with research and 
development of iPSCs and RM, 21.6% said they would like to cooperate by offering 
cells and/or blood, but 69.4% said they would like to wait and see the results of 
further research. Only 9.1% of respondents said they did not wish to cooperate (Fig. 
5).  
 With respect to the collection of information regarding iPSCs and RM, most 
people said they gained their information from the TV or internet, or from 
newspapers (73.5%). Contrary to this, 12.4% answered that they would like to 
search for information using the internet, and 6.0% said they would like to be 
informed through books or by attending seminars (Fig. 6). 60.0% of respondents had 
no experiences of conversations about iPSCs or RM.  
 We also determined opinions about the regulatory framework governing 
research and development into iPSCs and RM for medical applications. 63.0 % of 
respondents thought that Japan should have a regulatory framework based on 
international guidelines, while 23.0% thought that Japan should establish a proper 
regulatory system specifically for the Japanese situation (Fig. 7). The ethical issues 
surrounding the use of iPSCs to produce germ cells caused 30.3% of participants to 
respond that they believed the production of germ cells from iPSCs should be 
banned, while 58.4% thought it should be allowed to progress as long as it was 




Public Familiarity with and Prudence Regarding iPSCs  
 
The Japanese public generally accepted the necessity for extra funding and 
research into iPSCs and RM, and believed that RM would be realized in the near 
future (Figs. 1–3). This high level of recognition of a new type of stem cell was not 
found in a previous study in the United States [8]. Although the results of these two 
studies cannot be directly compared, the differences suggest a rapid change in social 
recognition. Although further studies are necessary, it seems likely that the rapid 
increase in mass-media broadcasting of iPSCs topics over the past 2 years may be 
responsible for this increased recognition [11].  
 It is worth noting that the Japanese public was not motivated to actively 
cooperate with the research and development of iPSCs and RM by offering their 
blood or cells at this stage (Fig. 5), but preferred to adopt a “wait and see” approach. 
Although it is difficult to judge the true meaning of the answers to this survey, the 
“wait and see” option favored by the public seems to suggest a prudent approach. 
Interestingly, this implies that a high level of recognition and acceptance of the 
necessity for research into iPSCs and RM does not directly impact the public’s 
motivation to actively cooperate. In order to investigate this point further, more 
detailed research into sources of information is needed, given that many people 
received their information on iPSCs and RM through the media (Fig. 6), and the 
amount and nature of this information is likely to affect public opinions. A previous 
study pointed out the possible correlation between public opinion and mass-media 
broadcasts regarding the issue of genetically modified food in Japan [12]. This 
aspect will be the subject of future research. 
 With regard to the sources of information, it should be emphasized that 
over 70% of the public received most of their information concerning iPSCs and RM 
solely from the television and newspapers (Fig. 6). Thus the cooperation between 
researchers, regulatory agencies and journalists is a critical factor when considering 
the flow of information. Active and effective disclosure of the latest developments in 
iPSC and RM research, including the risks involved, should be considered, because 
a balanced information supply is the basis for appropriate governance by the 
natural and social scientists, policymakers, journalists, and the public. The current 
situation, with increased interactions between scientists and journalists, works in a 
positive direction [13]. 
 
Requirement for Governance 
 
It is important to recognize that the Japanese public thought that research and 
development of iPSCs and RM should be conducted under proper governance, in 
accordance with an international regulatory framework (Fig. 7). In addition, 
approximately half of the respondents thought that it was important to progress 
with research and development with international cooperation (Fig. 4). Thus the 
establishment of proper governance at the international level needs to be discussed, 
and discussions relating to the regulatory framework for research and development 
into PSCs, including iPSCs, are currently being conducted at the highest levels 
worldwide. For example, several international guidelines concerning general 
research and the clinical application of PSCs were presented by the International 
Society for Stem Cell Research (ISSCR) [14,15]. However, the ISSCR is an academic 
society and their proposed guidelines cannot be legally enforced in all countries. 
Moreover, the pace of regulatory developments differs between countries. In 
January of this year, the United States FDA approved safety evaluations regarding 
the clinical applications of ES cells [16]. International consensus guidelines are 
required to cover the safety aspects of such research and its medical applications. 
 In order to formulate such international guidelines, it is imperative to 
actively involve regulatory agencies to oversee safety testing, risk evaluation of 
tumorigenicity and clinical research procedures for cellular therapeutics. Current 
reports that have discussed the tumorigenicity risk of PSCs have emphasized the 
importance of appropriate preclinical studies and have pointed out the necessity for 
rapid discussions on evaluating safety standards and the effectiveness of PSCs in 
clinical applications [17,18]. Yamanaka, one of the key researchers into iPSCs and 
RM, pointed out the risk of cancer due to iPSC implantation in long-term mouse 
experiments. He emphasized the importance of long-term safety and tumorigenicity 
risk evaluations [19]. Concerning this problem, a detailed description of regulatory 
systems will be needed, considering the potential problems that can arise from 
imperfect articulation of regulatory guidelines concerning the clinical applications 
of RM and biologics derived from stem cells [20].  
 In addition to the safety aspects, ethical aspects are also important. In this 
study, subjects were asked about the issue of making germ cell from iPSCs. More 
than half of the respondents thought that research should progress within a 
carefully established regulatory framework (Fig. 8). In Japan, a MEXT 
sub-committee approved the production of germ cells from PSCs for basic research 
in December 2008, though the fertilization of germ cells derived from PSCs is 
banned [21]. In the present study, we were unable to investigate in detail the public 
opinion on research concerned with making germ cells from iPSCs. In addition, this 
investigation was conducted over a different time period from that when the 
political decision on moderating research into making germ cells from iPSCs was 
made. Further research into the changes in public opinion and social, political, and 
scientific changes is needed. 
 Thus, in order to address the public requirement for the development of 
proper regulatory frameworks, it will be necessary to establish an international 
consensus on regulatory frameworks that has domestic legal authority to govern 
stem cell research and its application in each country. An internationally consistent 
regulatory system will promote future worldwide research and development into 
iPSCs and RM  
 
Conclusion 
The results of this study show that the Japanese public was familiar with the terms 
iPSCs and RM, and that they generally accepted the necessity of research into 
iPSCs. At the same time, they decided to adopt a “wait and see” approach, and 
thought that research and development into iPSCs and RM should be conducted 
under the proper regulations, in accordance with an international regulatory 
framework. This seems to demonstrate the prudence of the Japanese public. In 
order to address the public requirements, it will be necessary to discuss an 
international consensus on regulatory frameworks that have an impact on domestic 
stem cell research and its application in each country. It is also important to 
consider the methods of information flow concerning iPSCs and RM, and further 
research into this issue will be conducted.  
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Table.1 List of questions
Question sentence
• Do you know about iPS cells?
• Do you know about RM?
• How would you like to find out about iPS cells or RM?
• How long do you think it will take to realize RM?
• Which idea regarding research and development into iPS cells and RM 
is closest to your opinion?
• What do you think about the cost of research into iPS cells and RM?
• What do you think about the regulatory framework regarding the 
medical applications of research and development into iPS cells and 
RM?
• Which of the following ideas about the use of iPS cells to make germ 
cells is closest to your opinion?
• Do you think that research into iPS cells and RM is necessary?
• Do you mean ‘Is there anyone you know who would like to know more 
about RM?’, or ’Is there anyone you know who would like to receive 
RM?’ 
• Do you have any opportunity to talk about iPS cells or RM in your daily 
life?
• Would you be prepared to be actively involved in iPS cell research?
• What is your attitude towards research into iPS cells or advanced life 
sciences?
• How old are you
• What is your occupation?
• What is your sex?
%(n) Male Female Total
Under 19 0.5% (72) 0.3% (52) 0.8% (124)
20's 1.5% (219) 2.3% (344) 3.8% (563)
30's 5.9% (882) 6.8% (1021) 12.8% (1903)
40's 16.3% (2435) 11.1% (1694) 27.7% (4129)
50's 17.6% (2625) 10.0% (1488) 27.6% (4113)
60's 15.1% (2249) 4.9% (731) 20.0% (2980)
Over 70 6.3% (945) 1.0% (151) 7.4% (1096)
Total 63.2% (9427) 36.8% (5481) 100% (14908)
Table 2. Demographics of respondents.
Table.3 Public familiarity with iPSCs and RM
% (n)
Do you know RM?
Yes No Total

















Figure.1 Do you think that research into iPS cells and RM is 
necessary?







Figure.2 What do you think about the cost of research into iPS cells and 
RM?
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Figure.3 How long do you think it will take to realize RM?
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Figure.4 Which idea regarding research and development into iPS cells 
and RM is closest to your opinion?
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Figure.5 Would you be prepared to be actively involved in iPS cell 
research?
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Figure.6 How would you like to find out about iPS cells or RM?
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I would like to get more information from
books or seminars
I would like to find the information on the
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Figure.7 What do you think about the regulatory framework regarding 
the medical applications of research and development into iPS cells 
and RM?
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A specific Japanese regulatory system
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Figure.8 Which of the following ideas about the use of iPS cells to make 
germ cells is closest to your opinion?
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